New York – November 4, 2022 – AEA Investors’ Small Business Private Equity team announced today that its fund has closed the acquisition of Rees Scientific, Inc. alongside rollover investment from the Company’s employees. Established in 1982 and headquartered in Trenton, New Jersey, Rees is the largest provider of automated environmental monitoring solutions to the high-end life sciences market. Rees’ continuous environmental monitoring systems are integral to customers as they serve as a failsafe to protect the most sensitive and expensive (or in some cases, irreplaceable) assets within life sciences, including tissue samples, cell and gene therapy drugs, biologics, organs and blood.
Rees represents an exciting opportunity to invest in the large and growing life sciences instrumentation and measurement space, which has been an area of focus for AEA SBPE. The Company’s differentiated service network, industry leading product offering supported by proprietary software and long-term customer relationships with highly recurring revenue make Rees a highly attractive asset.
AEA Investors LP was founded in 1968 by the Rockefeller, Mellon and Harriman family interests and S.G. Warburg & Co. as a private investment vehicle for a select group of industrial family offices with substantial assets. AEA has an extraordinary global network built over many years which includes leading industrial families, business executives and leaders; many of whom invest with AEA as active individual investors and/or join its portfolio company boards or act in other advisory roles. Today, AEA’s approximately 110 investment professionals operate globally with offices in New York, Stamford, San Francisco, London, Munich and Shanghai. The firm manages funds that have approximately $18 billion of invested and committed capital including the leveraged buyouts of middle market companies and small business companies, growth capital and mezzanine and senior debt investments. AEA SBPE is a strategy within AEA that currently manages $2 billion of invested and committed capital. The team seeks to help grow and transform companies at the lower end of the middle market by sponsoring growing companies with proven management teams and superior business models.
Rees is the largest provider of automated environmental monitoring solutions to the high-end life sciences market. The Company’s system ensures customers operate within stringent regulatory guidelines. Rees serves customers across the biopharma, biotech, hospital, blood bank, academic and contract research organization end markets. Learn more at https://www.reesscientific.com/.